Mindstate Design Labs

Mindstate Design Labs provides therapeutically valuable emotions in pharmaceutical form. The Osmanthus platform is an ensemble of AI models that synthesize extensive datasets of psychoactive pharmacology and phenomenology, accurately identifying the neurotransmitter receptor activity combinations underlying various emotional, cognitive, and perceptual states. The lead program, MSD-001, is designed to act rapidly and enhance emotional and cognitive flexibility without inducing hallucinations. Currently in human trials, MSD-001 will serve as the base ingredient for multiple drug combinations, offering "emotions in a bottle" such as empathy, awe, clarity, or beauty.